David Lebwohl - EVP, Chief Medical Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Medical Officer
Issuer Symbol
NTLA on Nasdaq
All Insider Reports
All Insider Reports

David Lebwohl - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by David Lebwohl for Intellia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 131,192 $1,638,588 $12.49 01 Mar 2026 Direct
Stock Option (right to buy) 14,204 01 Mar 2026 Direct Common Stock

Transactions reported by David Lebwohl for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.